Company Search:
Advanced Search
Sponsored Links
DarioHealth Corp Company Snapshot
DarioHealth Corp operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares DarioHealth Corp with three other companies in this sector in the United States: ProQR Therapeutics NV (2018 sales of $6.79 million of which 100% was Pharmaceutical), Voyager Therapeutics Inc ($7.62 million of which 100% was Clinical-stage gene therapy company), and AC Immune SA ($7.36 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
DarioHealth Corp
  Stock Performance Chart for DarioHealth Corp
  Stock Data: Recent Stock Performance:
  Current Price (9/6/2019): .40
(Figures in U.S. Dollars)
1 Week 0.8%   13 Weeks -25.4%  
4 Weeks -16.0%   52 Weeks -59.3%  
DarioHealth Corp Key Data:
  Ticker: DRIO Country: Israel
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 7,394,000
(Year Ending Jan 2019).
Employees: 31
  Currency: U.S. Dollars Market Cap: 17,272,333
  Fiscal Yr Ends: December Shares Outstanding: 42,859,386
  Share Type: Ordinary Closely Held Shares: 13,997,582
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.